TY - CHAP M1 - Book, Section TI - Ranibizumab A1 - Ciccone, Charles D. PY - 2016 T2 - Davis's Drug Guide for Rehabilitation Professionals AB - ranibizumab (ran-i-bi-zoo-mab)LucentisClassificationTherapeutic: ocular agentsPharmacologic: monoclonal antibodies SN - PB - F. A. Davis Company CY - New York, NY Y2 - 2024/03/28 UR - fadavispt.mhmedical.com/content.aspx?aid=1134182296 ER -